IS OPTIMAL DOSE OF CAPECITABINE FOR DISSEMINATED BREAST CANCER TREATMENT FINALLY AND IRREVOCABLY DETERMINED?

O. Ivanova; Иванова О.; E. Zhiltsova; Жильцова Е.; P. Krivorotko; Криворотько П.; V. Ivanov; Иванов В.; H. Barash; Бараш Н.

IS OPTIMAL DOSE OF CAPECITABINE FOR DISSEMINATED BREAST CANCER TREATMENT FINALLY AND IRREVOCABLY DETERMINED?

Authors: Ivanova O.¹, Zhiltsova E.¹, Krivorotko P.¹, Ivanov V.¹, Barash H.¹
Affiliations:
1. Cancer Research Institute N.N. Petrov
Issue: Vol 23, No 12 (2012)
Pages: 57-60
Section: Articles
URL: https://journals.eco-vector.com/0236-3054/article/view/115579
ID: 115579

Cite item

Full Text

Open Access
Restricted Access

Access granted
Restricted Access

Subscription or Fee Access

Abstract
Full Text
About the authors
References
Supplementary files
Statistics

Abstract

Research data on optimal dose of Capecitabine for disseminated breast cancer treatment are provided. The optimal dose of Capecitabine 1000 мг/м 2 twice a day, applicable for long term treatment is provisionally determined.

Keywords

breast cancer, Capecitabine, optimal dose